Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by dshah  – India, 2022-03-29 20:40 (1137 d 11:22 ago) – Posting: # 22884
Views: 3,178

Dear Balakotu!
As per EMA- In parallel design studies, the treatment groups should be comparable in all known variables that may affect the pharmacokinetics of the active substance (e.g. age, body weight, sex, ethnic origin, smoking status, extensive/poor metabolic status). This is an essential pre-requisite to give validity to the results from such studies.
In general, it is recommended to have balanced between treatment arms.
Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
101 visitors (0 registered, 101 guests [including 9 identified bots]).
Forum time: 08:02 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5